Results 61 to 70 of about 35,686 (231)

Obvious Reduction of the Tumor Size in Dedifferentiated Liposarcoma in a Lung Metastasis Patient Receiving Individualized Treatment

Case Reports in Oncology, 2021
Abdominal metastasis is relatively rare in dedifferentiated liposarcoma of the shoulder and back. Surgery is the best treatment option, whether it is radical or palliative surgery. Chemotherapy is the standard systemic treatment for advanced unresectable/
Xin-Li Wang, Jia-Yao Gong, Yan Xue
doaj   +1 more source

Huge Dedifferentiated Liposarcoma of the Left Thigh with a High Grade Fibrosarcomatous Differentiation and a Local Recurrence [PDF]

Journal of Clinical and Diagnostic Research, 2013
Dedifferentiated liposarcoma is one of the variants of liposarcoma which has a more aggressive course. It constitutes less than 10% of all the liposarcomas and is often found in the retroperitoneum and the mediastinum. We are reporting a rare case of
Sunil V. Jagtap, Dhiraj B. Nikumbh, Swati S. Jagtap, Ashok Y. Kshirsagar, Anuya S. Badve   +4 more
doaj   +1 more source

Liposarcoma of the chest wall mimicking a breast mass in a man: a case report

Radiology Case Reports, 2021
We report a rare case of dedifferentiated liposarcoma in a man. A 60-year-old male patient presented with a left mass involving the whole breast area, with no lymph node enlargement, growing during a one-year-period.
Holub Priscila Giselle, MD, Castro Barba Mariana, MD, Fernandez Cintia, MD, Galvez Tatiana, MD, Fanelli Noelia, MD, Tachdjian Gabriela, MD, Oillataguerre Lorena, MD, Bermudez Soledad, MD, Prychodzko Cristina, MD, Hansen Lucila, MD, Hernández María Noel, MD, Naso Bibiana Fernanda, MD, Hauszpigiel Gustavo, MD   +12 more
doaj   +1 more source

Diaphragmatic liposarcoma with gall bladder invasion: CT and MRI findings

Radiology Case Reports, 2020
Primary liposarcoma originating from the diaphragm is an extremely rare case. Seventy-four-year-old male presented to emergency department with worsening right upper quadrant abdominal pain with dyspnea.
Beum Jin Kim, MBBS, Mi Sook Lee, MD
doaj   +1 more source

Dedifferentiated liposarcoma [PDF]

, 2020
Joachim Feger, Liz Silverstone, Rohit Sharma   +2 more
  +9 more sources

Clinical course and prognostic factors of patients with dedifferentiated liposarcoma: a retrospective analysis

BMC Cancer
Dedifferentiated liposarcoma (DDLPS) is a fairly common subtype of soft tissue sarcoma, but relatively little is known about the clinical course and prognostic factors of this mesenchymal malignancy.
Jelena Casier, I. Timmermans, A. Laenen, D. Hompes, T. Douchy, R. Sciot, M. Christiaens, Hazem Wafa, P. Schöffski   +8 more
semanticscholar   +1 more source

Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma

Cancer Medicine, 2022
Patients with unresectable dedifferentiated liposarcoma (DDLPS) have poor overall outcomes. Few genomic alterations have been identified with limited therapeutic options.
M. Jagosky, C. Anderson, J. Symanowski, N. Steuerwald, C. Farhangfar, Emily Baldrige, J. Benbow, M. Livingston, Joshua C. Patt, W. Ahrens, J. Kneisl, Edward S. Kim   +11 more
semanticscholar   +1 more source

Dedifferentiated Liposarcoma With Myofibroblastic Differentiation [PDF]

Archives of Pathology & Laboratory Medicine, 2018
Context.— Liposarcoma is divided into myxoid, pleomorphic, well-differentiated, and dedifferentiated subtypes. Dedifferentiated liposarcoma displays the greatest histomorphologic diversity, including a subset with myofibroblastic differentiation that shares similarities with a spectrum of reactive, benign, and ...
Grace Y, Wang, David R, Lucas
openaire   +2 more sources

A randomized, non-comparative phase 2 study of neoadjuvant immune checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Nature Cancer
Based on the demonstrated clinical activity of immune-checkpoint blockade (ICB) in advanced dedifferentiated liposarcoma (DDLPS) and undifferentiated pleomorphic sarcoma (UPS), we conducted a randomized, non-comparative phase 2 trial (NCT03307616) of ...
C. Roland, E. N. Nassif Haddad, E. Keung, Wei-Lien Wang, Alexander J. Lazar, Heather Lin, M. Chelvanambi, Edwin R. Parra, K. Wani, B. Guadagnolo, A. Bishop, E. Burton, K. K. Hunt, Keila E. Torres, B. Feig, Christopher P. Scally, Valerae O. Lewis, J. Bird, R. Ratan, D. Araujo, M. Zarzour, Shreyaskumar R. Patel, R. Benjamin, A. Conley, J. Livingston, V. Ravi, H. Tawbi, Patrick P. Lin, Bryan S. Moon, R. Satcher, Bilal Mujtaba, R. Witt, R. Traweek, B. Cope, Rossana N. Lazcano, Chia-Chin Wu, Xiao Zhou, M. M. Mohammad, Randy Chu, Jianhua Zhang, Ashish V. Damania, P. Sahasrabhojane, T. Tate, K. Callahan, S. Nguyen, D. Ingram, Rohini R. Morey, S. Crosby, G. Mathew, Sheila Duncan, C. Lima, J. Blay, W. Fridman, K. Shaw, I. Wistuba, Andrew P. Futreal, Nadim Ajami, J. Wargo, N. Somaiah   +58 more
semanticscholar   +1 more source

Cellular origin and clonal evolution of human dedifferentiated liposarcoma

Nature Communications
Dedifferentiated liposarcoma (DDLPS) is the most frequent high-grade soft tissue sarcoma subtype. It is characterized by a component of undifferentiated tumor cells coexisting with a component of well-differentiated adipocytic tumor cells.
N. Gruel, C. Quignot, L. Lesage, S. El Zein, S. Bonvalot, D. Tzanis, Khadija Ait Rais, Fabien Quinquis, Bastien Manciot, J. Vibert, Nadine El Tannir, A. Dahmani, H. Derrien, Didier Decaudin, Ivan Bièche, L. Courtois, O. Mariani, Laetitia K. Linares, L. Gayte, S. Baulande, Joshua J. Waterfall, O. Delattre, G. Pierron, S. Watson   +23 more
semanticscholar   +1 more source